Blinded, Double-Dummy, Parallel-Group, Phase 2a Randomized Clinical Trial to Evaluate the Efficacy and Safety of a Highly Selective 5-Hydroxytryptamine Type 4 Receptor Agonist in Critically Ill Patients With Enteral Feeding Intolerance.

Chapman, Marianne J; Jones, Karen L; Almansa, Cristina; Barnes, Chris N; Nguyen, Deanna; Deane, Adam M

Chapman, Marianne J; Jones, Karen L; Almansa, Cristina; Barnes, Chris N; Nguyen, Deanna; Deane, Adam M.

Afiliación

Chapman MJ; Discipline of Acute Care Medicine, University of Adelaide, Adelaide, South Australia, Australia.
Jones KL; Intensive Care Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Almansa C; Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia.
Barnes CN; Takeda Development Center Americas, Inc., Cambridge, Massachusetts, USA.
Nguyen D; Theravance Biopharma US, Inc., South San Francisco, California, USA.
Deane AM; Theravance Biopharma US, Inc., South San Francisco, California, USA.

JPEN J Parenter Enteral Nutr ; 45(1): 115-124, 2021 01.

Article en En | MEDLINE | ID: mdl-31990087

Asunto(s)

Enfermedad Crítica; Preparaciones Farmacéuticas; Método Doble Ciego; Nutrición Enteral; Vaciamiento Gástrico; Humanos; Recién Nacido; Metoclopramida; Serotonina

Palabras clave

TAK-954 (td-8954); critically ill; enteral feeding intolerance; gastric emptying; metoclopramide; scintigraphy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Preparaciones Farmacéuticas / Enfermedad Crítica Tipo de estudio: Clinical_trials Límite: Humans / Newborn Idioma: En Revista: JPEN J Parenter Enteral Nutr Año: 2021 Tipo del documento: Article País de afiliación: Australia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google